STAT+: On Day 4 of JPM, a chat with Regeneron’s George Yancopoulos, an IPO forecast, and all eyes on J&J
This is the online version of The Readout, STAT’s flagship biotech newsletter. Sign up to get it in your inbox.
We have made it! And so have you. This is Adam, Elaine, Matt, and Allison preparing to sign off from JPM26.
And yet — we have one closing act. Join us at 1 p.m. ET tomorrow for a virtual recap of the conference, where we’ll talk about what we learned about the state of biotech, and what it portends for the year ahead.
Allison DeAngelis, Matthew Herper, Adam Feuerstein, and Elaine Chen
Go to statnews